Monday, August 21, 2017
 
 
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Kalorama Information Names Top Seven Companies in Point-of-Care Diagnostics
 
(March 20, 2017)

ROCKVILLE, Md., March 20, 2017 /PRNewswire/ -- Roche, Alere, Abbott, Siemens are among the largest companies in point of care (POC) diagnostics in terms of revenues, according to Kalorama Information.  Point-of-care systems are designed to deliver test results in a location and timing to be useful during a patient visit.  They consist of devices such as glucose meters, operated by a patient, or small analyzers operated in a physician office lab.  Together these companies make up three-fourths of the entire market for point of care diagnostics.   The market research firm with a specialty in IVD made the assessment in its latest report The World Market for Point of Care Diagnostics.

According to the report, the top seven companies in POC testing are: 


  • Roche  
  • Alere   
  • Abbott   
  • Danaher (Beckman and Radiometer Divisions)
  • LifeScan  
  • Ascensia Diabetes Care   
  • Siemens Healthineers  

The firm said 2016 revenues were used to make the assessment.  Market share within POC categories can be found in Kalorama Information's report.  The firm said that Roche dominated POC diagnostics as it leads in several IVD categories.  Coagulation and glucose testing are key areas.  In June 2015, Roche introduced the cobas c 513 blood glucose analyzer. It is a dedicated, high-throughput HbA1c analyzer suitable for diagnosis, monitoring and risk identification of diabetes patients.   

Waltham, MA-based Alere secured the second market position Alere participates in nearly all POC test segments but has a dominating position in rapid cardiac markers, blood glucose including HbA1c, coagulation, drugs of abuse, infectious disease, lipid and pregnancy and fertility testing.   The company has had challenges recently.  The company said it was examining "inappropriate conduct" at the South Korean unit, Standard Diagnostics and federal investigations into Alere's government billing practices and foreign sales plagued the company last year.  Yet in the point of care market, it is a dominant brand. 

Abbott Laboratories, who had made a bid to acquire Alere last year, (now tied up in court and not likely to result in a merged company) held the third position.  Abbott offers a good selection of POC tests. Abbott's strongest area of sales is in the blood glucose monitoring market.  The introduction of the i-STAT Total ?-hCG, a handheld blood test for pregnancy has helped POC sales for Abbott.    

Danaher is fourth.  Its Beckman Coulter unit participates in several POC testing segments and is a leader in POC blood and electrolytes testing, colon cancer screening, infectious disease and cancer testing markets.  And Danaher's Radiometer participates in the blood and electrolytes and cardiac marker testing.

LifeScan is a leader in the blood glucose monitoring and large volume sales there put the company in fifth place.  Participating companies in the blood glucose market have been targeted by generics and discounted products available online the company and its Ultra line was hard hit.

Ascensia Diabetes Care secured sixth place in the market due to the aforementioned issues in the glucose testing market.  Siemens Healthineers is a major participant in POC testing for blood and electrolytes, rapid coagulation, rapid cardiac markers, drugs of abuse and urinalysis tests and earned seventh place.

The remaining market share is held by large, small and start-up companies including Abraxis, Accriva, bioMérieux, Ortho Diagnostics, Response Biomedical, Church & Dwight, Quidel, Prestige Brands, Meridian BioScience, Helena Labs, Polymedco, Enterix, Exact, OraSure, Trinity Biomedical, Abaxis, Polymer Technologies, EKF Diagnostics, Eiken Chemical, IL, Nova Biomedical, OPKO Health, Sysmex, and many others, Together these companies account for approximately $4.1 billion in revenues for  2016.   

Kalorama Information's Point of Care (POC) Diagnostics is available at https://www.kaloramainformation.com/Point-Care-POC-10616559/.

More of Kalorama's diagnostics market reports can be found at: https://www.kaloramainformation.com/diagnostics-market-c1125/

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.  

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.  

Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.

Press Contact:
Bruce Carlson
212 807 2262 
[email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-information-names-top-seven-companies-in-point-of-care-diagnostics-300422738.html

SOURCE Kalorama Information

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Disease, healthcare, Pregnancy, Technology, Surgery, Medication, Pregnancy, Physician, Science, Medical Technology, Medical, Biology, Cancer, Medical Professionals,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Medical Sector Contract Electronic Manufacturing Market shows lucrative growth CAGR of 8.8 % by 2022
  • BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
  • Global Contrast Injector Market Will Reach USD 889.3 Million by 2022: Zion Market Research
  • Ascension Teams with Plug and Play Tech Center to Connect with Health and Wellness Startups
  • Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 - Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.

    Cancer
  • Gaucher Disease Market Is Anticipated To Witness Growth Owing To Increasing R&D Activities And Special Facility For Orphan Drugs Till 2021 | Million Insights
  • CytRx Corporation Files Preliminary Proxy Statement for Upcoming Special Meeting
  • Astronauts Showcase Space Art Created with Childhood Cancer Patients
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines